James D. Chalmers
School of Medicine, University of Dundee, UK · University of Dundee, Nethergate, Dundee DD1 4HN, Scotland, UK
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James D. Chalmers as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:41 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06166056 · A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With BronchiectasisChiesi Farmaceutici S.p.A. · completed · Bronchiectasis · principal investigator
- Ph3NCT05006573 · Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis BronchiectasisAstraZeneca · terminated · Non-cystic Fibrosis Bronchiectasis · principal investigator
- N/ANCT03791086 · The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and EndotypingUniversity of Dundee · recruiting · Bronchiectasis Adult
- N/ANCT02179983 · Tayside Rehabilitation in Bronchiectasis Exacerbations (TRIBE) : a Randomized Controlled TrialNHS Tayside · terminated · Bronchiectasis
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:41 UTC. The ranking covers the 200 most relevant of 36 PubMed records, and a shared surname and initials can bring in a namesake. All 36 on PubMed
- Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.Am J Respir Crit Care Med · 2012327 citationsRCR 11.6
- Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.N Engl J Med · 2020320 citationsRCR 16.3
- Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.J Allergy Clin Immunol · 2018248 citationsRCR 9.7
- A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.Am J Respir Crit Care Med · 2011222 citationsRCR 8.2
- Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.N Engl J Med · 2025176 citationsRCR 53.9
- Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.Lancet Respir Med · 2019174 citationsRCR 9.2
- Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study.Eur Respir J · 202587 citationsRCR 29.2
- Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.Lancet Respir Med · 201474 citationsRCR 2.6
- 72 citationsRCR 8.0
- Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.Cytokine · 201663 citationsRCR 2.5